Travaux scientifiques

Prof. Dr. Doğan Uncu

218 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Prognostic and Predictive Value of NAR Score in Gastric Cancer

    Journal of Gastrointestinal Cancer, 2020

    DOI 10.1007/s12029-020-00537-2 PMID 33064272 4 citations (OpenAlex) Source : OpenAlex

  2. Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?

    Cureus, 2020

    DOI 10.7759/cureus.10525 PMID 33094066 6 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  3. Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer

    Medicine, 2020

    DOI 10.1097/md.0000000000022407 PMID 32991469 24 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  4. Relationship between Health Literacy and Medication Adherence of Turkish Cancer Patients Receiving Oral Chemotherapy

    Asia-Pacific Journal of Oncology Nursing, 2020

    DOI 10.4103/apjon.apjon_30_20 PMID 33062832 14 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  5. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?

    Journal of Research in Medical Sciences, 2020

    DOI 10.4103/jrms.jrms_1056_18 PMID 32174986 14 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  6. Retrospective Analysis of Pure Ovarian Immature Teratoma in Patients Aged 15–39 Years: A Turkish Multicenter Study

    Journal of Adolescent and Young Adult Oncology, 2020

    DOI 10.1089/jayao.2020.0155 PMID 33296263 4 citations (OpenAlex) Source : OpenAlex

  7. HER2-pozitif lokal ileri meme kanserinde neoadjuvan trastuzumab sıralamasının patolojik tam yanıt üzerine etkisi

    Bozok Tıp Dergisi, 2020

    DOI 10.16919/bozoktip.569169 Texte intégral en libre accèsSource : OpenAlex

  8. Sınırlı Evre Küçük Hücreli Akciğer Kanseri Tedavisi

    2020

    Source : OpenAlex

  9. The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer

    Medicine, 2020

    DOI 10.1097/md.0000000000023168 PMID 33235077 Texte intégral en libre accèsSource : OpenAlex

  10. Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.

    Journal of Clinical Oncology, 2019

    DOI 10.1200/jco.2019.37.15_suppl.e16075 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  11. KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer

    Expert review of molecular diagnostics, 2019

    DOI 10.1080/14737159.2019.1693266 PMID 31718325 8 citations (Europe PMC) Source : Europe PMC

  12. Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study.

    PubMed, 2019

    PMID 31646831 16 citations (OpenAlex) Source : OpenAlex

  13. The comparison of oxaliplatin or irinotecan rechallenge treatment with regorafenib in the third-line treatment of metastatic colorectal cancer

    Acta Oncologica Turcica, 2019

    DOI 10.5505/aot.2019.83703 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  14. Capecitabine plus temozolomide (CapTem): An alternative regimen to regorafenib as third-line setting in metastatic colorectal cancer?

    PubMed, 2019

    PMID 31983117 1 citation (OpenAlex) Source : OpenAlex

  15. The Difference in Clinical and Prognostic Features Between De Novo and Recurrent Her2-Positive Metastatic Breast Cancer Patients

    Acta Medica, 2019

    DOI 10.32552/2019.actamedica.395 Texte intégral en libre accèsSource : OpenAlex

  16. Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder

    Oncology Research and Treatment, 2018

    DOI 10.1159/000486598 PMID 29558755 2 citations (Europe PMC) Source : OpenAlex

  17. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)

    Journal of Cancer Research and Therapeutics, 2018

    DOI 10.4103/0973-1482.176417 PMID 29893321 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  18. Classic Kaposi's sarcoma: A review of 156 cases

    Dermatologica Sinica, 2018

    DOI 10.1016/j.dsi.2018.06.005 10 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  19. Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

    OncoTargets and Therapy, 2018

    DOI 10.2147/ott.s106342 PMID 29403286 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  20. Outcomes of Turkish National Breast Cancer Registry.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e12517 3 citations (OpenAlex) Source : OpenAlex

  21. Characteristics of Turkish colorectal cancer patients and bevacizumab preference.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e15055 Source : OpenAlex

  22. Evaluation of Lymphoma Patients Receiving High-Dose Therapy and Autologous Stem Cell Transplantation: Experience of a Single Center

    Indian Journal of Hematology and Blood Transfusion, 2017

    DOI 10.1007/s12288-016-0756-x PMID 28824238 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  23. Non-transitional Cell Carcinoma of The Bladder: Single Center Experience

    Acta Oncologica Turcica, 2017

    DOI 10.5505/aot.2017.83007 Texte intégral en libre accèsSource : OpenAlex

  24. Mesanenin Transisyonel Hücreli Olmayan Kanserleri: Tek Merkez Deneyimi

    Acta Oncologica Turcica, 2017

    Texte intégral en libre accèsSource : OpenAlex

  25. A Retrospective Evaluation of Patients with Operable Gastrointestinal Stromal Tumor

    Acta Oncologica Turcica, 2016

    DOI 10.5505/aot.2016.93064 Source : OpenAlex

  26. Evaluation of the effects of red blood cell distribution width on survival in lung cancer patients

    Współczesna Onkologia, 2016

    DOI 10.5114/wo.2016.60072 PMID 27358595 19 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  27. Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer

    Wiener Klinische Wochenschrift, 2016

    DOI 10.1007/s00508-015-0724-8 PMID 25720573 28 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  28. Abstract P3-01-21: Is lymph node ratio (LNR) having additional contribution for predict prognosis on pathologic lymph node staging in node-positive breast cancer patients?

    Cancer Research, 2016

    DOI 10.1158/1538-7445.sabcs15-p3-01-21 Source : OpenAlex

  29. Turkish National Gastric Cancer Registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12645 Texte intégral en libre accèsSource : OpenAlex

  30. Turkish National Breast Cancer Registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12654 Source : OpenAlex

  31. Association of obesity with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12657 Source : OpenAlex

  32. Turkish National Colon Cancer Registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12646 Texte intégral en libre accèsSource : OpenAlex

  33. Geographic variations of clinical characteristics in breast cancer: Analysis of Turkish National Breast Cancer Registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12656 Source : OpenAlex

  34. Effect of body mass index in gastric cancer patients: Analysis of Turkish national gastric cancer registry.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e15056 Texte intégral en libre accèsSource : OpenAlex

  35. Duodenal adenocarcinoma: A rare cause of chyloperitoneum (chylous ascites)

    Indian Journal of Cancer, 2015

    DOI 10.4103/0019-509x.175565 PMID 26837993 Source : ORCID

  36. 2292 The prognostic significance of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and prognostic nutritional index in metastatic pancreas cancer

    European Journal of Cancer, 2015

    DOI 10.1016/s0959-8049(16)31208-4 1 citation (OpenAlex) Source : OpenAlex

  37. Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.9.3997 PMID 25987075 42 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  38. Breast cancer subtypes and the risk of distant relapse after breast conserving surgery or mastectomy: An Anatolian Society of Medical Oncology study.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e12052 Texte intégral en libre accèsSource : OpenAlex

  39. Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology Study

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.9.4127 PMID 25987098 6 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  40. Treatment modalities in primary gastric lymphoma: effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology

    Współczesna Onkologia, 2014

    DOI 10.5114/wo.2014.40556 PMID 25258586 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  41. The clinical and pathologic characteristics of 400 gastrointestinal stromal tumor patients from Turkey: The final results of the Turkish Anatolian Society of Medical Oncology Multicenter Registery.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e15176 Source : OpenAlex

  42. Turkish Breast Cancer Registry: A multicenter epidemiologic study.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e12518 Source : OpenAlex

  43. Adjuvant chemotherapy outcomes in patients over 65 years with early stage colorectal carcinoma.

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2014

    PMID 25536594 Texte intégral en libre accèsSource : ORCID

  44. Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale"

    Wiener Klinische Wochenschrift, 2014

    DOI 10.1007/s00508-013-0453-9 PMID 24249323 12 citations (Europe PMC) Source : ORCID

  45. Treatment and Outcomes of Ewing Sarcoma in Turkish Adults: A Single Centre Experience

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.1.327 PMID 24528050 10 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  46. EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER

    Annals of Oncology, 2014

    DOI 10.1093/annonc/mdu327.44 Texte intégral en libre accèsSource : ORCID

  47. Acupuncture as a Complementary Treatment for Cancer Patients Receiving Chemotherapy

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.7.3139 PMID 24815460 46 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  48. Evaluation of erectile dysfunction risk factors in young male survivors of colorectal cancer.

    PubMed, 2014

    PMID 24659652 17 citations (OpenAlex) Source : OpenAlex

  49. Clinicopathologic Features and Prognosis of Osteosarcoma in Turkish Adults

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.8.3537 PMID 24870753 12 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  50. Treatment and Prognostic Factors in Primary Peritoneal Carcinoma: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO)

    Oncology Research and Treatment, 2014

    DOI 10.1159/000362857 PMID 24903764 7 citations (OpenAlex) Source : OpenAlex